Health Care/Hospital

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III ...

2026-03-02 08:00 6121

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

SAN FRANCISCO and SUZHOU, China, March 1, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...

2026-03-02 08:00 6575

Investor Education Webinar

The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders to discuss a physician's perspective on innova...

2026-03-02 06:56 4133

Nearly 4,000 Participants Join "On Track to Save 2026" as Revived Orienteering Competition Draws Over 100 Family Teams

HONG KONG, March 1, 2026 /PRNewswire/ -- Médecins Sans Frontières (MSF) Hong Kong successfully held its large‑scale running and orienteering competition, "On Track to Save 2026", today at the Hong Kong Science Park. The event saw its highest participation in recent years, withnearly 4,000 partici...

2026-03-01 14:57 5190

Dimora Medical Supports NPIAP 2026 Annual Conference as Exclusive Opening Ceremony Sponsor

NEW YORK, Feb. 28, 2026 /PRNewswire/ -- From February 26 to 27, the NPIAP 2026 Annual Conference was held inthe United States, bringing together leading clinicians, researchers, and healthcare professionals to advance the prevention and management of pressure injuries. Dimora Medical, a continuou...

2026-02-28 23:56 4806

BestQool's BQ60Pro: Next-Generation 6-Wavelength Home Red Light Therapy Device with Enhanced Output and Smarter Flexibility

NEW YORK, Feb. 27, 2026 /PRNewswire/ -- Since the launch of BestQool , this company has always aimed to deliver the most for its customers and continuously improve its home-use products,...

2026-02-28 01:36 6644

Vatech Reports Industry-Leading 20-Year Patent Portfolio in Dental Diagnostic Imaging

Patent leadership reinforces company's leading position in the global CBCT market HWASEONG, South Korea, Feb. 27, 2026 /PRNewswire/ -- Vatech (KOSDAQ: 043150), a global manufacturer of dental imaging systems, announced that cumulative patent data over the past 20 years demonstrate its technologi...

2026-02-27 22:00 6146

Prof. Mike Chan and Leigh Steinberg Launch "Concussion" Book at Super Bowl Brain Health Summit 2026

SAN FRANCISCO, Feb. 27, 2026 /PRNewswire/ -- European Wellness Biomedical Group, through its education division European Wellness Academy, is pleased to announce the official launch of "Concussion: The Hidden Trauma in Contact Sports and the NFL," co-authored by legendary NFL sports agent Leigh S...

2026-02-27 18:04 5001

WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform

SHANGHAI, Feb. 27, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic collaboratio...

2026-02-27 17:11 6503

Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform

WILMINGTON, Del., Feb. 27, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) on WuXi XDC's proprietary WuXiTecan...

2026-02-27 15:00 5213

Medit Announces "Glow Together" International Women's Day Campaign

SEOUL, South Korea, Feb. 27, 2026 /PRNewswire/ -- Medit, a global provider of digital dentistry solutions, today announced that the "Glow Together" campaign will begin this March. The 'Glow Together' initiative began with small steps taken by the female employees of Medit. Light becomes more powe...

2026-02-27 13:00 6577

ASEAN Foundation introduced CALM MRI: Children and the No Longer Scary Machine

SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- The ASEAN Foundation organized the regional programme"CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as a platform to present the programme's outcomes, w...

2026-02-27 12:39 3909

Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

SUZHOU, China, Feb. 27, 2026 /PRNewswire/ -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. ...

2026-02-27 10:49 8491

Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026

SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the com...

2026-02-27 10:33 8902

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

* TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases * 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered sta...

2026-02-27 08:00 7826

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 26, 2026 /PRNewswire/ -- Intravesical BCG is the standard of care (SOC) for BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and coupled with the side effects of BCG therapy itself,me...

2026-02-27 08:00 6132

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC) platform to support e...

2026-02-27 05:01 5624

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

Highlights: * First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS * Approximately 160 participants with ALS will be enrolled in a 36-week randomised,double-blind, placebo-controlled adaptive Phase 2/3 clin...

2026-02-27 04:34 7456

ArisGlobal Launches NavaX Translation to Eliminate Manual Translation in Global Pharmacovigilance

Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety workflows BOSTON, Feb. 26, 2026 /PRNewswire/ -- ArisGlobal

2026-02-26 22:12 5858

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

* SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines inEurope to improve vaccine performance and access. * Parallel development of high-immunogenicity HD-MAP vaccines for seasonal and pandemic influenza threats. INCHEON, South Korea,...

2026-02-26 21:00 7291
1 ... 42434445464748 ... 858